MedPath

Comparison of Levonorgestrel Intrauterine System, Copper T Intrauterine Device and Oral Contraceptives on Life Quality

Phase 4
Withdrawn
Conditions
Contraceptive Methods Comparison
Interventions
Device: The Copper-T is an intrauterine device (IUD)
Device: levonorgestrel-releasing system
Registration Number
NCT01805817
Lead Sponsor
Istanbul Training and Research Hospital
Brief Summary

Oral combined contraceptives(OC) have both progesterone and estrogen inside. Levonorgestrel-releasing intrauterine device(LNG_IUS) has only progestagen.

Copper IUD does not have any hormonal molecule inside.

* Hypothesis is OC has more systemic beneficial or side effects than LNG_IUS or copper IUD. LNG_IUS has more local effects than copper IUD.

* Study reflects the beneficial or side effects of estrogen+progestagen pills and only progestogen inside device.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  • women who desire contraception
Exclusion Criteria
  • Women with large fibroids,abnormal uterine bleeding including heavy menstrual bleeding or using any contraceptive pills during the previous 3 months were excluded from the study. Other exclusion criteria were pelvic inflammatory disease, pregnancy, genital tumor or thromboembolic disease.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Levonorgestrel releasing intrauterine device, contraceptionThe Copper-T is an intrauterine device (IUD)LNG-IUS - Mirena ®,20μgr, once intrauterine insertion per 5 year, 1 year
Levonorgestrel releasing intrauterine device, contraceptionlevonorgestrel-releasing systemLNG-IUS - Mirena ®,20μgr, once intrauterine insertion per 5 year, 1 year
YASMIN® (Drospirenone/Ethinyl Estradiol), contraceptionThe Copper-T is an intrauterine device (IUD)oral, once a day, 1 year
YASMIN® (Drospirenone/Ethinyl Estradiol), contraceptionlevonorgestrel-releasing systemoral, once a day, 1 year
Copper T 380 A , contraceptionThe Copper-T is an intrauterine device (IUD)intrauterine device, once per 10 year, 1 year period
Copper T 380 A , contraceptionlevonorgestrel-releasing systemintrauterine device, once per 10 year, 1 year period
Levonorgestrel releasing intrauterine device, contraceptionYASMIN® (Drospirenone/Ethinyl Estradiol)LNG-IUS - Mirena ®,20μgr, once intrauterine insertion per 5 year, 1 year
YASMIN® (Drospirenone/Ethinyl Estradiol), contraceptionYASMIN® (Drospirenone/Ethinyl Estradiol)oral, once a day, 1 year
Copper T 380 A , contraceptionYASMIN® (Drospirenone/Ethinyl Estradiol)intrauterine device, once per 10 year, 1 year period
Primary Outcome Measures
NameTimeMethod
Lipid profile (HDL,VLDL,IDL,LDL,Lp(a),VLDL)Lng-ius users, Copper-iud users and combined oral contraceptive users (composite measurement)Change from Baseline HDL,Very-low-density lipoprotein (VLDL),IDL,Low-density lipoprotein (LDL),Lp(a),VLDL concentrations at 3 months; Baseline to 6 months, Baseline to 12 months of outcome will have assessed

60 lng-ius users, 60 Copper iud users and 60 combined oral contraceptive users will compared with total lipoprotein, high-density lipoprotein (HDL), low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL), lipoprotein(a) (Lp(a)), intermediate-density lipoprotein (IDL ), HDL subclasses , LDL subclasses , VLDL subclasses ,values at 3-6-12 months follow up.

Secondary Outcome Measures
NameTimeMethod
coagulation parameters(composite measurement)Change from Baseline aPTT, prothrombin time, INR, D-dimer,factor VIII, fibrinogen, platelet counts values at 3 months; Baseline to 6 months, Baseline to 12 months of outcome will have assessed

60 lng-ius users, 60 Copper iud users and 60 combined oral contraceptive users will compared with activated partial thromboplastin time (aPTT), prothrombin time, international normalized ratio(INR), D-dimer,factor VIII, fibrinogen, platelet counts values with each other at 3-6-12 months follow up.

Trial Locations

Locations (1)

Istanbul Training and Research Hospital

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath